ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726444 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726444; 2) Community: the network communities that were significantly associated with the response to NSC 726444; 3) Molecule: the relationships between components within communities and NSC 726444; 4) MDR: the compounds that were significantly associated with the NSC 726444.

NSC Compound Enrichment Correlation
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0490935610249067 0.43692823
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0490935610249067 0.54283474
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0490935610249067 0.088662751
NSC 359239 Antibiotic X-14766A 0.0490935610249067 -0.15105475
NSC 371777 Null 0.0490935610249067 0.38900793
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0490935610249067 0.14995479
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0490935610249067 0.41052364
NSC 45236 Null 0.0490935610249067 0.19683224
NSC 5332 2-Hydroxy-1-(2-pyridylazo)naphthalene 0.0490935610249067 0.38231803
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0490935610249067 0.33281412
Total:91  Current:86    [First] [Prev] [Next] [Last]